Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Legit Cannabis Dealers Contending With Counterfeit Sites
Cannabis businesses in New York are growing increasingly frustrated over counterfeiting. Cheddar News spoke with Peter Tang, founder of Plugplay and Dr. Nima Majlesi of Staten Island University Hospital about the effects of counterfeiting.
Load More